Related references
Note: Only part of the references are listed.The FcγRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell-depleted kidney transplant recipients - a retrospective study
Philippe Gatault et al.
TRANSPLANT INTERNATIONAL (2020)
A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
Rolf Anton Klaasen et al.
THERAPEUTIC DRUG MONITORING (2019)
Antithymocytes globulins: Time to revisit its use in kidney transplantation?
D. Ducloux et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2018)
Population Pharmacokinetics of Brentuximab Vedotin in Patients With CD30-Expressing Hematologic Malignancies
Hong Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
The appropriate dose of thymoglobulin induction therapy in kidney transplantation
Mohsen Nafar et al.
CLINICAL TRANSPLANTATION (2017)
Evaluation of antithymocyte globulin pharmacokinetics and pharmacodynamics in children
Naim Bouazza et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Population Pharmacokinetic Modeling of Thymoglobulin (R) in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing
Rick Admiraal et al.
CLINICAL PHARMACOKINETICS (2015)
Population Pharmacokinetic Modelling of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Patients with Haemophilia B
Lei Diao et al.
CLINICAL PHARMACOKINETICS (2014)
New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
Mohamad Mohty et al.
DRUGS (2014)
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients
David Ternant et al.
PHARMACOGENETICS AND GENOMICS (2014)
Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: Results of a randomized trial
Matthias Buechler et al.
TRANSPLANT IMMUNOLOGY (2013)
Monitoring of CD3+ T-Cell Count in Patients Receiving Antithymocyte Globulin Induction After Cadaveric Renal Transplantation
P. Ata et al.
TRANSPLANTATION PROCEEDINGS (2013)
The role of Thymoglobulin induction in kidney transplantation: an update
Georges Mourad et al.
CLINICAL TRANSPLANTATION (2012)
The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients
M. M. L. Kho et al.
TRANSPLANT IMMUNOLOGY (2012)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Low-Dose Rabbit Antithymocyte Globulin Induction Therapy Results in Prolonged Selective Lymphocyte Depletion Irrespective of Maintenance Immunosuppression
O. Pankewycz et al.
TRANSPLANTATION PROCEEDINGS (2011)
Immune Reconstitution Following Rabbit Antithymocyte Globulin
S. Gurkan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Rabbit Antithymocyte Globulin (Thymoglobulin (R)) 25 Years and New Frontiers in Solid Organ Transplantation and Haematology
A. Osama Gaber et al.
DRUGS (2010)
Total and Active Rabbit Antithymocyte Globulin (rATG;Thymoglobulin®) Pharmacokinetics in Pediatric Patients Undergoing Unrelated Donor Bone Marrow Transplantation
Sandra K. Call et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin
Anthe S. Zandvliet et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Population PK-PD model for Fc-osteoprotegerin in healthy postmenopausal women
Matthew L. Zierhut et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2008)
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation
Waichi Wong et al.
TRANSPLANT INTERNATIONAL (2006)
Hematological response of topotecan in tumor-bearing rats:: Modeling of the time course of different cellular populations
C Segura et al.
PHARMACEUTICAL RESEARCH (2004)
Rituximab-dependent cytotoxicity by natural killer cells:: Influence of FCGR3A polymorphism on the concentration-effect relationship
S Dall'Ozzo et al.
CANCER RESEARCH (2004)
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation
EK Waller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Model of chemotherapy-induced myelosuppression with parameter consistency across drugs
LE Friberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
General pharmacokinetic model for drugs exhibiting target-mediated drug disposition
DE Mager et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Total and active thymoglobulin levels: effects of dose and sensitization on serum concentrations
JF Regan et al.
TRANSPLANT IMMUNOLOGY (2001)
Share Paper
